08.28.26 -- For Bispecific Ab Programs, Measure Twice And Outsource Once

Delve into strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.

Spray dry technology is being leveraged to create shelf-stable, dry-powder vaccines to treat and prevent the spread of tuberculosis which could significantly improve our global response to disease.

Learn how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules.

In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.

Three factors often decide success or failure in FIH studies: integrating biomarkers and pharmacodynamic endpoints, including patients in the trials, and leveraging manufacturing infrastructure.

A challenge in drug development can be finding a team capable of carrying a molecule through the complexities between the lab and the patient. See three considerations that build a partnership.

Explore the versatility and significance of LFHCs in pharmaceutical and nutraceutical delivery, as well as their role in enhancing drug solubility, bioavailability, and overall efficiency.